日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.

miR-18 靶向 TGFβ 特征及其重要成分 CTGF 与胶质母细胞瘤患者生存率的提高相关

Fox Jamie L, Dews Michael, Minn Andy J, Thomas-Tikhonenko Andrei

p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers.

p53 反应性 miR-194 抑制血小板反应蛋白-1 并促进结肠癌血管生成

Sundaram Prema, Hultine Stacy, Smith Lauren M, Dews Michael, Fox Jamie L, Biyashev Dauren, Schelter Janell M, Huang Qihong, Cleary Michele A, Volpert Olga V, Thomas-Tikhonenko Andrei

The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors

myc-miR-17~92轴抑制TGFβ信号传导和多种TGFβ依赖性抗血管生成因子的产生。

Dews, Michael; Fox, Jamie L; Hultine, Stacy; Sundaram, Prema; Wang, Wenge; Liu, Yingqiu Y; Furth, Emma; Enders, Gregory H; El-Deiry, Wafik; Schelter, Janell M; Cleary, Michele A; Thomas-Tikhonenko, Andrei

Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis

癌基因和表观遗传因素对CLU基因表达的调控及其对肿瘤发生的影响

Sala, Arturo; Bettuzzi, Saverio; Pucci, Sabina; Chayka, Olesya; Dews, Michael; Thomas-Tikhonenko, Andrei

Aiding and ABT'ing Treatment for Glioblastoma

辅助和 ABT 治疗胶质母细胞瘤

Chung, Elaine Y; Dews, Michael; Maity, Amit; Thomas-Tikhonenko, Andrei

Inactivation of Myc in murine two-hit B lymphomas causes dormancy with elevated levels of interleukin 10 receptor and CD20: implications for adjuvant therapies.

小鼠二次打击 B 淋巴瘤中 Myc 失活导致休眠,白细胞介素 10 受体和 CD20 水平升高:对辅助治疗的意义

Yu Duonan, Dews Michael, Park Andrea, Tobias John W, Thomas-Tikhonenko Andrei

Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity

c-myc对FLIP表达的直接抑制是TRAIL敏感性的主要决定因素。

Ricci, M Stacey; Jin, Zhaoyu; Dews, Michael; Yu, Duonan; Thomas-Tikhonenko, Andrei; Dicker, David T; El-Deiry, Wafik S